Since dysregulation of p53 and its downstream targets, MDM2 in particular, are tightly linked to tumorigenesis including breast cancer, we next chose several representative genes and validated their expressions in MCF-7 cells by qRT-PCR. This evidence concerns the gene MDM2 and breast carcinoma.